Summit Creek Advisors Has Lowered Cavium (CAVM) Holding; Yara International ASA (YARIY) Had 1 Bullish Analysts

December 2, 2017 - By Ellis Scott

Summit Creek Advisors Llc decreased Cavium Inc. (CAVM) stake by 6.84% reported in 2017Q2 SEC filing. Summit Creek Advisors Llc sold 11,783 shares as Cavium Inc. (CAVM)’s stock rose 6.47%. The Summit Creek Advisors Llc holds 160,605 shares with $9.98 million value, down from 172,388 last quarter. Cavium Inc. now has $5.91 billion valuation. The stock decreased 0.08% or $0.07 during the last trading session, reaching $85.41. About 2.24 million shares traded or 55.87% up from the average. Cavium, Inc. (NASDAQ:CAVM) has risen 55.16% since December 2, 2016 and is uptrending. It has outperformed by 38.46% the S&P500.

Among 5 analysts covering Yara ASA (OTCMKTS:YARIY), 1 have Buy rating, 2 Sell and 2 Hold. Therefore 20% are positive. Yara ASA had 7 analyst reports since July 22, 2015 according to SRatingsIntel. Bernstein downgraded Yara International ASA (OTCMKTS:YARIY) on Tuesday, September 1 to “Mkt Perform” rating. The firm has “Sell” rating by Citigroup given on Monday, October 26. Societe Generale upgraded Yara International ASA (OTCMKTS:YARIY) on Thursday, October 29 to “Buy” rating. JP Morgan upgraded the stock to “Neutral” rating in Wednesday, July 22 report. The stock of Yara International ASA (OTCMKTS:YARIY) has “Mkt Perform” rating given on Thursday, January 7 by Bernstein. Zacks upgraded the stock to “Sell” rating in Friday, August 28 report. Howard Weil upgraded the stock to “Underperform” rating in Tuesday, August 25 report. See Yara International ASA (OTCMKTS:YARIY) latest ratings:

Yara International ASA provides industrial and environmental products in Norway and internationally. The company has market cap of $12.55 billion. It operates through the Crop Nutrition, Industrial, and Production divisions. It has a 33.86 P/E ratio. The firm offers ammonia, urea, nitrates, and other nitrogen products; crop nutrition products, such as nitrogen, phosphorus, potassium, calcium, magnesium, boron, copper, iron sulfur, manganese, molybdenum, and zinc; calcium ammonium nitrate, ammonium nitrate, urea ammonium nitrate solutions, ammonium sulfate, composite fertilizer products, and field-grade calcium nitrate fertilizers; fertigation and liquid fertilizers, including calcium nitrate, potassium nitrate, and micronutrient chelates, which are used in drip irrigation, sprinkler systems, and pivot agriculture; and foliar products.

The stock decreased 1.25% or $0.555 during the last trading session, reaching $43.855. About 10,710 shares traded or 54.28% up from the average. Yara International ASA (OTCMKTS:YARIY) has 0.00% since December 2, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 24 analysts covering Cavium Networks Inc. (NASDAQ:CAVM), 11 have Buy rating, 1 Sell and 12 Hold. Therefore 46% are positive. Cavium Networks Inc. had 68 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was maintained by Oppenheimer on Wednesday, June 14 with “Hold”. The rating was maintained by Benchmark on Wednesday, November 2 with “Buy”. As per Thursday, August 3, the company rating was maintained by Rosenblatt. The rating was maintained by Oppenheimer on Thursday, August 3 with “Hold”. JP Morgan maintained the shares of CAVM in report on Tuesday, September 13 with “Overweight” rating. The rating was maintained by Susquehanna with “Buy” on Thursday, August 3. The firm earned “Buy” rating on Wednesday, October 18 by Jefferies. The company was maintained on Thursday, November 2 by Loop Capital Markets. Canaccord Genuity maintained it with “Hold” rating and $6600 target in Monday, July 10 report. The firm earned “Buy” rating on Tuesday, May 3 by Brean Capital.

Analysts await Cavium, Inc. (NASDAQ:CAVM) to report earnings on February, 7. They expect $0.44 EPS, up 100.00% or $0.22 from last year’s $0.22 per share. CAVM’s profit will be $30.43M for 48.53 P/E if the $0.44 EPS becomes a reality. After $0.36 actual EPS reported by Cavium, Inc. for the previous quarter, Wall Street now forecasts 22.22% EPS growth.